- Q1 2024 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2024$33.2 (+3.69%)Earnings
- Arrowhead Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q4 2023 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 29, 2023$28.98 (+0.21%)Earnings
- Arrowhead Pharmaceuticals Inc Analyst and Investor Event on Plozasiran and Zodasiran (Virtual) TranscriptNov 13, 2023
- Arrowhead Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q3 2023 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2023$30.81 (-2.65%)Earnings
- Arrowhead Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Arrowhead Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Arrowhead Pharmaceuticals Inc R&D Day TranscriptJun 01, 2023
- Q2 2023 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2023$35.38 (-0.95%)Earnings
- Q1 2023 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2023$33.51 (-8.79%)Earnings
- Arrowhead Pharmaceuticals Inc to Present Topline Data from the Phase 2 SEQUOIA Study TranscriptJan 09, 2023
- Q4 2022 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 28, 2022$28 (-5.08%)Earnings
- Arrowhead Pharmaceuticals Inc Analyst and Investor Event TranscriptNov 09, 2022
- Q3 2022 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$46.13 (+3.99%)Earnings
- Arrowhead Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Arrowhead Pharmaceuticals Inc Pulmonary R&D Day TranscriptMay 26, 2022
- Arrowhead Pharmaceuticals Inc at UBS Global Healthcare Conference TranscriptMay 25, 2022
- Arrowhead Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Arrowhead Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q2 2022 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2022$34.29 (+4.80%)Earnings
- Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMar 17, 2022
- Q1 2022 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 02, 2022$52.63 (-4.48%)Earnings
- Q4 2021 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 22, 2021$69.28 (-2.57%)Earnings
- Arrowhead Pharmaceuticals Inc ARO-C3 KOL Webinar TranscriptOct 26, 2021
- Arrowhead Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Q3 2021 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$68.05 (+2.92%)Earnings
- Arrowhead Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Arrowhead Pharmaceuticals Inc at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- Q2 2021 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2021$66.48 (-5.35%)Earnings
- Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMar 18, 2021
- Q1 2021 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 04, 2021$83.92 (+4.47%)Earnings
- Q4 2020 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 23, 2020$68.2 (-0.87%)Earnings
- Arrowhead Pharmaceuticals Inc Key Opinion Leader Webinar on ARO-ANG3 TranscriptNov 19, 2020
- Arrowhead Pharmaceuticals Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Arrowhead Pharmaceuticals Inc Key Opinion Leader Webinar on ARO-APOC3 TranscriptNov 18, 2020
- Arrowhead Pharmaceuticals Inc and Takeda Pharmaceutical Co Ltd Collaboration and Licensing Agreement to Develop ARO-AAT Conference Call TranscriptOct 08, 2020
- Q3 2020 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2020$43.56 (-1.27%)Earnings
- Arrowhead Pharmaceuticals Inc Key Opinion Leader Webinar on ARO-ENaC TranscriptJul 28, 2020
- Arrowhead Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Arrowhead Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q2 2020 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$35.13 (+2.63%)Earnings
- Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMar 19, 2020
- Arrowhead Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q1 2020 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 05, 2020$43.72 (-0.41%)Earnings
- Q4 2019 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 25, 2019$56.99 (+15.83%)Earnings
- Arrowhead Pharmaceuticals Inc Analyst R&D Day TranscriptOct 18, 2019
- Q3 2019 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2019$27.24 (-6.46%)Earnings
- Arrowhead Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q2 2019 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019$18.33 (+1.78%)Earnings
- Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMar 14, 2019
- Arrowhead Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q1 2019 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2019$13.3 (-3.90%)Earnings
Arrowhead Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Hi, Everyone. My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. I'm happy to welcome our guests Vince Anzalone, Head of IR; and James Hamilton, Chief Discovery and Translational Medicine of Arrowhead. This is going to be a fireside chat format. So maybe to start off, if you guys want to provide a brief intro to Arrowhead.
Sure. Thanks, Mark, and thanks to the whole Jefferies team for having us today. So, Arrowhead is an RNAi therapeutics platform company. So, we have a proprietary technology platform called TRiM or targeted RNA molecules. It allows us to induce target gene silencing across multiple tissue types, including liver, lung, muscle, CNS, and emerging adipose. Right now, we have 12 clinical stage candidates, 7 of those are wholly owned, 5 are partnered. And we have a 20 in '25 initiative, where we want to grow our pipeline of both clinical stage and marketed products to 20 by the year 2025.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)